Insulet
PODD
#1935
Rank
HK$83.03 B
Marketcap
HK$1,199
Share price
3.82%
Change (1 day)
-52.91%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2026 (TTM): HK$33.56

According to Insulet's latest financial reports the company's current EPS (TTM) is HK$33.67. In 2025 the company made an earnings per share (EPS) of HK$27.41 a decrease over its 2024 EPS that were of HK$46.83.

EPS history for Insulet from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$33.5622.44%
2025HK$27.41-41.47%
2024HK$46.83102.71%
2023HK$23.104114.29%
2022HK$0.55-69.57%
2021HK$1.80109.09%
2020HK$0.86-38.89%
2019HK$1.41200%
2018HK$0.47-113.04%
2017-HK$3.60-9.8%
2016-HK$3.99-60.47%
2015-HK$10.1038.71%
2014-HK$7.2812.05%
2013-HK$6.50-23.15%
2012-HK$8.46-12.2%
2011-HK$9.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.41 103.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$28.26-16.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$28.11-16.51%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
HK$221.02 556.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-HK$24.04-171.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
HK$0.16-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
HK$18.79-44.19%๐Ÿ‡บ๐Ÿ‡ธ USA